Allosteric hemoglobin modifiers which decrease oxygen affinity in blood
US5250701A · kind A · utility
4Cited by
5References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 19, 1993 |
| Grant date | Oct 5, 1993 |
| Priority date | — |
| Expiry date | Jan 19, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A family of compounds has been found to be useful for right-shifting hemoglobin towards a low oxygen affinity state. The compounds are capable of acting on hemoglobin in whole blood. In addition, the compounds can maintain the oxygen affinity in blood during storage and can restore the oxygen affinity of outdated blood.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.